Business Update Positive

2026-11-06 12:01

Management Guidance & Outlook - Maintained FY27 revenue growth guidance of 10% to 15%. - FY27 EBITDA margin guided between 18% to 20%, driven by better product mix and seasonal strength in H2. - Expects European demand to recover in H2 FY27 following temporary heat and drought impacts in H1. Capex & Product Registrations - Planned capex for FY27 is ₹550 Cr to ₹600 Cr, dedicated to product registrations (₹419 Cr spent in H1 FY27, including US data compensation). - Total product registrations stood at 3,044 as of September 30, 2026, with 946 applications pending in the pipeline. Growth Drivers & Operational Performance - NAFTA revenue grew ~30% YoY with strong gross margins of ~40%, while LATAM agrochem revenue rose over 80% YoY. - Non-agrochemical revenue grew 68% YoY to ₹212 Cr in Q2 FY27, propelled by high demand for conveyor belts. - Debt-free balance sheet with cash and liquid investments totaling ₹846 Cr as of September 30, 2026.

Business Update Neutral

2026-11-02 18:05

- Audio recording link made available for the Q2 FY 2026-27 earnings conference call. - The call was conducted on November 2, 2026, at 3:00 PM IST.

Business Update Positive

2026-10-30 13:59

- Q2 FY27 Consolidated Revenue grew 13% YoY to ₹1,052 Cr. - EBITDA increased 18% YoY to ₹164 Cr with margin expanding to 15.6%. - PAT rose 23% YoY to ₹92 Cr. - Maintained FY27 guidance of 10–15% revenue growth and 18–20% EBITDA margin. - Debt-free with cash and investments of ₹846 Cr.

Business Update Neutral

2026-10-30 13:56

- Investor Presentation released for Q2 & H1 ended September 30, 2026. - Presence spans 80+ countries with 525+ distributors and 3,044 registrations. - Incurred Capex of ₹419 Cr during H1 FY27. - Continues to drive growth via an asset-light, IP-led model and expanding global distribution.

Business Update Neutral

2026-10-30 13:52

- Sharda Cropchem released its Investor Presentation for Q2 & H1 FY27. - The company reported an asset-light, IP-led business model with 3,044 registrations across 80+ countries. - SCL incurred ₹419 Cr Capex in H1 FY27, backed by 525+ distributors and 500+ sales professionals globally.

Financials Neutral

2026-10-30 13:33

Q2 FY27 Consolidated Revenue ₹1,051.68Cr vs ₹929.11Cr (▲13.2% YoY) EBITDA ₹164.11Cr vs ₹132.87Cr (▲23.5% YoY) PAT ₹91.73Cr vs ₹74.36Cr (▲23.4% YoY) EBITDA Margin 15.60% vs 14.30% (▲130bps)

Business Update Neutral

2026-10-27 17:56

Concall Schedule Concall Date: 2nd November 2026 Concall Time: 3:00 p.m. (IST)

Routine Neutral

2026-09-28 13:15

- Trading window for dealing in company securities will remain closed from October 1, 2026. - Closure will continue until 48 hours after the declaration of financial results for the quarter and half-year ending September 30, 2026.

Business Update Neutral

2026-09-01 12:05

- Investor Conference Schedule - Conference Date: 21st September 2026 - Conference Time: 10:00 AM to 1:00 PM - Organised by: Anand Rathi Annual Flagship Conference G-200 Summit 2026 - Venue: Taj Santacruz, Mumbai

Business Update Positive

2026-08-04 15:47

- Q1 FY27 Consolidated Revenue ₹1,074 crores (▲9% YoY) - EBITDA ₹178 crores (▲25% YoY) - EBITDA Margin 16.6% (▲220 bps YoY) - Gross margins expanded by 120 bps to 36.7%. - Agrochemical business grew 8% YoY, non-Agrochemical business grew 15% YoY. - Europe market saw temporary softening due to unusual heatwave conditions, but volumes are expected to recover; NAFTA and LATAM delivered strong growth. - Company remains debt-free with cash and liquid investments of ₹767 crores. - FY27 guidance maintained: 10-15% revenue growth, 35-37% gross margins, and 18-20% EBITDA margin. - Expects 5-10% volume growth for FY27, with CAPEX around ₹500-550 crores.

Business Update Neutral

2026-07-30 18:09

- Audio recording of the Q1 FY 2026-27 Financial Results conference call is available. - The call was conducted on 30th July, 2026 at 03:30 P.M. (IST). - A link to the audio recording is provided for investors and analysts.

Financials Positive

2026-07-29 14:24

- Consolidated Revenue ₹1,074Cr vs ₹985Cr (▲9% YoY) - EBITDA ₹178Cr vs ₹142Cr (▲25% YoY) - PAT ₹88Cr vs ₹143Cr (▼38% YoY) - EBITDA Margin 16.6% vs 14.4% (▲220bps)

Financials Negative

2026-07-29 14:13

- Consolidated Revenue ₹1073.77Cr vs ₹984.81Cr (▲9.03% YoY) - EBITDA ₹185.98Cr vs ₹215.29Cr (▼13.61% YoY) - PAT ₹88.02Cr vs ₹142.80Cr (▼38.36% YoY) - EBITDA Margin 17.32% vs 21.86% (▼454bps)

Business Update Neutral

2026-07-22 12:37

- Concall Schedule - Concall Date: 30th July, 2026 - Concall Time: 03:30 P.M. IST - Purpose: To discuss 1QFY27 earnings.

Routine Neutral

2026-07-14 11:25

New Filing detected. See link for details.

Governance Positive

2026-07-02 16:11

- The 23rd Annual General Meeting (AGM) will be held on Friday, 14th August, 2026, at 01:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). - The Record Date for determining eligibility for final dividend for FY 2025-26 is Friday, 7th August, 2026. - The Register of Members and Share Transfer Books will remain closed on Saturday, 8th August, 2026, for the purpose of the AGM.

Governance Positive

2026-07-02 16:09

- Intimation of 23rd Annual General Meeting (AGM) on 14th August 2026 at 01:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). - Record Date for determining eligibility for final dividend for FY25-26 is 7th August 2026. - Book Closure Date for the purpose of AGM is 8th August 2026.

Routine Neutral

2026-06-26 11:34

- Trading window for dealing in company securities will remain closed from July 1, 2026. - It will open 48 hours after the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026, are approved and filed. - The date of the Board meeting to approve these results will be informed later.

Business Update Positive

2026-05-19 11:31

Management reported FY26 as the best year in company history, driven by strong revenue, EBITDA, and PAT. For FY27, management guided for revenue growth of 10-15%, EBITDA margins of 18-20%, and gross margins around 35%. Volume growth is expected around 15%. The company remains debt-free with significant cash reserves (INR 702 Cr as of March 31, 2026) and incurred a CAPEX of INR 505 Cr in FY26. Growth drivers include recovery in the global agrochemical market, ability to pass on raw material price increases, and continuous investment in product registrations (3,011 registrations, 1,004 in pipeline). The company sees significant scope for market share improvement, with continued demand for agrochemicals globally.

Business Update Neutral

2026-05-18 18:48

Sharda Cropchem Limited announced the schedule of an Analyst / Institutional Investor Meeting on 29th May 2026, from 11:00 AM to 2:00 PM. The meeting, organized by 360 One Capital (B&K) - Trinity India 2026, will be held at Grand Hyatt, Mumbai. Discussions will be based on publicly available information, and no unpublished price sensitive information (UPSI) will be shared.

Business Update Neutral

2026-05-14 16:23

Sharda Cropchem Limited announced the availability of the audio recording for its conference call with analysts and investors regarding the Q4 FY 2025-26 Audited Financial Results. The call was conducted on Thursday, May 14, 2026, at 01:00 P.M. (IST), and the audio link is accessible on the company's website.

Financials Positive

2026-05-14 12:53

Sharda Cropchem Limited's Board of Directors, at their meeting on May 13, 2026, considered and recommended a final dividend of Rs. 9.00 per equity share of face value Rs. 10.00 each for the financial year 2025-26. This recommendation is subject to the approval of shareholders at the forthcoming Annual General Meeting.

Financials Positive

2026-05-13 18:34

Sharda Cropchem Limited's Board of Directors, in a meeting held on May 13, 2026, recommended a final dividend of Rs. 9.00 per equity share for the financial year 2025-26. The dividend, on shares with a face value of Rs. 10.00 each, is subject to approval by shareholders at the forthcoming Annual General Meeting.

Financials Positive

2026-05-13 15:01

Consolidated Revenue ₹2,065 Cr vs ₹1,829 Cr (▲13% YoY), EBITDA ₹513 Cr vs ₹293 Cr (▲75% YoY), PAT ₹319 Cr vs ₹204 Cr (▲57% YoY). EBITDA Margin 24.8% vs 16.0% (▲880bps). The company also recommended a final dividend of ₹9 per equity share, bringing the total dividend for FY26 to ₹15 per share.

Financials Positive

2026-05-13 14:35

Sharda Cropchem Limited reported strong consolidated annual results for the year ended March 31, 2026. Consolidated Revenue from operations was ₹5,267.59 Cr vs ₹4,319.85 Cr (▲22% YoY). EBITDA stood at ₹1,181.77 Cr vs ₹655.11 Cr (▲80% YoY), and Net Profit (PAT) was ₹680.99 Cr vs ₹304.42 Cr (▲124% YoY). The EBITDA Margin expanded significantly to 22.43% from 15.16% (▲727bps). The Board also recommended a final dividend of Rs. 9.00 per equity share for FY26.

Business Update Neutral

2026-05-06 16:39

Sharda Cropchem Limited has scheduled a conference call for analysts and investors on Thursday, 14th May 2026, at 01:00 P.M. IST. The purpose of the call is to discuss the company's 4Q and FY26 earnings. Senior management, including the Chairman & Managing Director, CFO, and Company Secretary, will participate.

Routine Neutral

2026-04-03 18:16

Sharda Cropchem Limited submitted the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026, regarding details of dematerialized/rematerialized securities.

Routine Neutral

2026-03-26 18:14

Sharda Cropchem Limited announced the closure of its trading window from April 1st, 2026, until 48 hours after the Audited Financial Results for the quarter and financial year ended March 31st, 2026, are approved and filed with the Stock Exchanges. The Board meeting date will be informed in due course.

Business Update Neutral

2026-03-04 18:37

Sharda Cropchem Limited announced an Analyst/Institutional Investor Group Meeting on March 10, 2026, from 4:00 PM to 5:00 PM, organized by Arihant Capital. The virtual meeting will discuss publicly available information, with no unpublished price sensitive information intended to be shared.

Business Update Neutral

2026-02-23 15:52

Sharda Cropchem Limited's credit rating for short-term bank facilities of Rs. 456 crore has been reaffirmed at 'Crisil A1+' by Crisil Limited on February 23, 2026.

Business Update Positive

2026-02-03 12:20

Transcript of the Q3 FY 2025-26 earnings call held on January 30, 2026. The company reported strong financial performance with 39% YoY revenue growth, 59% YoY EBITDA growth, and 366% YoY PAT growth, along with an interim dividend of ₹6 per share.

Financials Neutral

2026-01-30 16:32

Sharda Cropchem Limited announced the availability of the audio recording for its Q3 FY 2025-26 earnings call with Analysts/Investors, conducted on January 30, 2026. A link to the recording is provided.

SHARDACROP

Sharda Cropchem Ltd

Price Chart

Filing History

Unlock Full History